From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: the discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples